Pet Anthelmintic Drugs Market Scope And Analysis

  • Report Code : TIPRE00013986
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Pet Anthelmintic Drugs Market Analysis and Scope 2021-2031

Buy Now

Pet Anthelmintic Drugs Market Report Pet Anthelmintic Drugs Market Size and Share Pet Anthelmintic Drugs Market Scope and Analysis

Pet Anthelmintic Drugs Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 5.5%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Target Pathogen
  • Ascaris Lumbricoides [Roundworm]
  • Trichuris Trichiura [Whipworm]
  • Enterobius Vermicularis [Pinworm]
  • Ancylostoma Duodenale [Hookworm]
By Distribution Channel
  • Veterinary Pharmacies
  • Veterinary Hospitals and Clinics
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Novartis AG
  • Cipla Inc
  • Sun Pharmaceutical Industries Ltd
  • Amneal Pharmaceuticals LLC Impax Laboratories Inc
  • Zoetis Inc
  • GlaxoSmithKline plc
  • Bayer AG
  • Merck Co Inc Intervet Inc
  • Boehringer Ingelheim International GmbH
  • Virbac
    		•